Global Regenerative Medicine Market Set to Register 12.8% CAGR due to Rising Tissue Engineering and Stem Cell Therapy Transparency Market Research has published a new report on the global regenerative medicine market. As per the report, the global regenerative medicine market stood at US$2.6 bn in 2012 and is predicted to reach US$6.5 bn by 2019. The report, titled ‘Regenerative Medicine Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the global regenerative medicine market is expected to expand at a 12.80% CAGR during the period from 2013 to 2019 due to factors such as technological innovations in biomaterials, the increasing prevalence of joint disorders, and the increasing number of orthopedic surgeries. Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. The U.S. National Institutes of Health defines regenerative medicine as the process of creating functional tissues to replace and repair organ or tissue damaged due to congenital defects, age, or disease. Regenerative medicines boast wide-ranging applications in neurology, cardiovascular, musculoskeletal, and orthopedic diseases and ailments.
The report studies the global regenerative medicine market from ground-up covering the market definition, segmentation on the basis of various parameters, and factors influencing its growth trajectory. To present a granular analysis, the global regenerative medicine market is segmented on the basis of technology, by application, and regionally. The market study enumerates the various advancements impacting the regenerative medicine market, and incorporates in-depth study on its competitive landscape by profiling the prominent enterprises. To present valuable insights pertaining to the market’s growth metrics, the report includes Porter’s five forces analysis, market attractiveness analysis, and key players’ analysis. Overview of Global Regenerative Medicine Market The latest technologies introduced in tissue engineering and stem cell therapy are anticipated to give a significant impetus to the global regenerative medicine (bone and joint) market. In addition, the rising incidence of joint disorders and bone injuries has also considerably aided the expansion of the global market for regenerative medicine. However, the market faces challenges from stringent regulatory compliance, risk of post implantation rejection, and ethical issues